Overview

Adhesion Performance Study of Lidocaine Topical System 1.8% Compared to Generic Lidocaine Patch 5% in Healthy, Adult, Human Subjects

Status:
Completed

Trial end date:
2018-09-09

Target enrollment:

Participant gender:

Summary

An open label, randomized, two-treatment, two-period, single-dose study evaluating the product adhesion in healthy, adult subjects using ZTlido 1.8% Topical System and a generic Lidocaine Patch 5%

Phase:

Phase 1

Details

Lead Sponsor:

Scilex Pharmaceuticals, Inc.

Treatments:

Lidocaine